Analysts: Medicines Co (MDCO.O)

MDCO.O on Nasdaq

26.34USD
27 Apr 2015
Change (% chg)

$-1.07 (-3.90%)
Prev Close
$27.41
Open
$27.52
Day's High
$27.81
Day's Low
$26.30
Volume
696,859
Avg. Vol
1,224,880
52-wk High
$32.44
52-wk Low
$19.92

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.09 December 27 Apr 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 6 6 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.27 2.27

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 9 170.78 204.20 122.10 --
Quarter Ending Sep-15 9 180.99 239.00 123.90 --
Year Ending Dec-15 6 663.09 765.00 501.60 811.30
Year Ending Dec-16 11 736.23 974.54 256.17 795.82
Earnings (per share)
Quarter Ending Jun-15 8 -0.09 0.31 -0.59 --
Quarter Ending Sep-15 8 -0.04 0.56 -0.58 --
Year Ending Dec-15 6 -0.97 -0.04 -2.40 1.46
Year Ending Dec-16 9 0.11 1.89 -2.86 1.29

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 189.79 191.00 1.21 0.64
Quarter Ending Sep-14 188.26 172.40 15.86 8.42
Quarter Ending Jun-14 183.74 183.77 0.03 0.02
Quarter Ending Mar-14 175.57 177.24 1.67 0.95
Quarter Ending Dec-13 182.57 185.00 2.43 1.33
Earnings (per share)
Quarter Ending Dec-14 -0.82 -0.33 0.49 -59.90
Quarter Ending Sep-14 -0.12 -0.26 0.14 -120.15
Quarter Ending Jun-14 -0.02 -0.08 0.06 -249.34
Quarter Ending Mar-14 -0.05 -0.08 0.03 -55.64
Quarter Ending Dec-13 0.11 0.02 0.09 81.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 170.78 170.78 189.18 189.39 --
Quarter Ending Sep-15 180.99 180.99 190.71 189.74 --
Year Ending Dec-15 663.09 663.09 759.97 765.53 811.30
Year Ending Dec-16 736.23 736.23 801.56 781.62 795.82
Earnings (per share)
Quarter Ending Jun-15 -0.09 -0.09 0.17 0.18 --
Quarter Ending Sep-15 -0.04 -0.04 0.16 0.15 --
Year Ending Dec-15 -0.97 -0.97 0.32 0.52 1.46
Year Ending Dec-16 0.11 0.11 1.36 1.05 1.29

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-15 0 0 0 5
Quarter Ending Sep-15 0 0 1 4
Year Ending Dec-15 0 0 0 6
Year Ending Dec-16 0 0 0 5
Earnings
Quarter Ending Jun-15 0 0 0 5
Quarter Ending Sep-15 0 0 1 4
Year Ending Dec-15 0 0 0 6
Year Ending Dec-16 0 0 0 4

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks